Mohamed E. E. Shams

1.2k total citations
32 papers, 904 citations indexed

About

Mohamed E. E. Shams is a scholar working on Molecular Biology, Oncology and Psychiatry and Mental health. According to data from OpenAlex, Mohamed E. E. Shams has authored 32 papers receiving a total of 904 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Psychiatry and Mental health. Recurrent topics in Mohamed E. E. Shams's work include Pharmacogenetics and Drug Metabolism (5 papers), Cancer Treatment and Pharmacology (4 papers) and Treatment of Major Depression (4 papers). Mohamed E. E. Shams is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Cancer Treatment and Pharmacology (4 papers) and Treatment of Major Depression (4 papers). Mohamed E. E. Shams collaborates with scholars based in Egypt, Germany and Oman. Mohamed E. E. Shams's co-authors include Borros Arneth, Christoph Hiemke, Sebastian Härtter, Karl J. Lackner, Michael J. Müller, Rolf Kaiser, Mohammed M.H. Al-Gayyar, Stefan Unterecker, Gudrun Hefner and Tanja Falter and has published in prestigious journals such as International Journal of Molecular Sciences, American Journal of Obstetrics and Gynecology and Life Sciences.

In The Last Decade

Mohamed E. E. Shams

29 papers receiving 858 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohamed E. E. Shams Egypt 15 231 187 171 158 147 32 904
Hedi Schelleman United States 19 225 1.0× 99 0.5× 359 2.1× 164 1.0× 85 0.6× 30 1.1k
Menger Chung United States 17 194 0.8× 87 0.5× 173 1.0× 262 1.7× 102 0.7× 29 891
Mahesh N. Samtani United States 24 594 2.6× 162 0.9× 55 0.3× 282 1.8× 204 1.4× 57 1.4k
Jesús Reviriego Spain 19 60 0.3× 265 1.4× 284 1.7× 103 0.7× 149 1.0× 70 1.4k
Sang-Goo Shin South Korea 17 95 0.4× 193 1.0× 127 0.7× 91 0.6× 92 0.6× 47 752
Mike Ufer Switzerland 25 172 0.7× 273 1.5× 381 2.2× 131 0.8× 399 2.7× 67 1.9k
Kyoung Soo Lim South Korea 22 150 0.6× 255 1.4× 352 2.1× 237 1.5× 237 1.6× 84 1.5k
David W. J. Clark New Zealand 17 72 0.3× 199 1.1× 129 0.8× 163 1.0× 108 0.7× 37 944
Prajakti A. Kothare United States 22 157 0.7× 480 2.6× 104 0.6× 330 2.1× 187 1.3× 35 1.8k
J. Van Harten Netherlands 17 312 1.4× 103 0.6× 242 1.4× 315 2.0× 210 1.4× 34 1.1k

Countries citing papers authored by Mohamed E. E. Shams

Since Specialization
Citations

This map shows the geographic impact of Mohamed E. E. Shams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed E. E. Shams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed E. E. Shams more than expected).

Fields of papers citing papers by Mohamed E. E. Shams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed E. E. Shams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed E. E. Shams. The network helps show where Mohamed E. E. Shams may publish in the future.

Co-authorship network of co-authors of Mohamed E. E. Shams

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed E. E. Shams. A scholar is included among the top collaborators of Mohamed E. E. Shams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed E. E. Shams. Mohamed E. E. Shams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mansour, Noha O., et al.. (2025). Efficacy of using pentoxifylline in patients undergoing breast cancer surgery. Frontiers in Pharmacology. 16. 1560805–1560805. 1 indexed citations
3.
Mansour, Noha O., et al.. (2023). The clinical outcomes of dapagliflozin in patients with acute heart failure: A randomized controlled trial (DAPA-RESPONSE-AHF). European Journal of Pharmacology. 961. 176179–176179. 15 indexed citations
4.
Mansour, Noha O., et al.. (2023). Effect of cilostazol on preventing paclitaxel‐induced neuropathy in patients with breast cancer: A randomized controlled trial. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(9). 872–882. 7 indexed citations
5.
6.
7.
Hefner, Gudrun, Mohamed E. E. Shams, Stefan Unterecker, Tanja Falter, & Christoph Hiemke. (2015). Inflammation and psychotropic drugs: the relationship between C-reactive protein and antipsychotic drug levels. Psychopharmacology. 233(9). 1695–1705. 62 indexed citations
8.
Hefner, Gudrun, Stefan Unterecker, Mohamed E. E. Shams, et al.. (2015). Melperone but not bisoprolol or metoprolol is a clinically relevant inhibitor of CYP2D6: evidence from a therapeutic drug monitoring survey. Journal of Neural Transmission. 122(11). 1609–1617. 9 indexed citations
9.
Shams, Mohamed E. E., et al.. (2014). Adherence to medication among outpatient adolescents with epilepsy. Saudi Pharmaceutical Journal. 23(1). 33–40. 91 indexed citations
10.
Hiemke, Christoph & Mohamed E. E. Shams. (2013). Phenotyping and Genotyping of Drug Metabolism to Guide Pharmacotherapy in Psychiatry. Current Drug Delivery. 10(1). 46–53. 17 indexed citations
11.
Shams, Mohamed E. E., et al.. (2013). Formulation and In-vitro Evaluation of Loratadine Ocuserts. 3(4). 3 indexed citations
12.
Shams, Mohamed E. E.. (2011). Implementation of an E-Prescribing Service: Users' Satisfaction and Recommendations. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 144(4). 186–191. 6 indexed citations
13.
Al-Gayyar, Mohammed M.H., et al.. (2011). Fish oil improves lipid metabolism and ameliorates inflammation in patients with metabolic syndrome: Impact of nonalcoholic fatty liver disease. Pharmaceutical Biology. 50(3). 297–303. 23 indexed citations
14.
15.
Shams, Mohamed E. E., et al.. (2010). Measuring the rate of therapeutic adherence among outpatients with T2DM in Egypt. Saudi Pharmaceutical Journal. 18(4). 225–232. 78 indexed citations
16.
Arneth, Borros, Mohamed E. E. Shams, Christoph Hiemke, & Sebastian Härtter. (2009). Rapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or/and duplication of the CYP2D6 gene. Clinical Biochemistry. 42(12). 1282–1290. 14 indexed citations
17.
Shams, Mohamed E. E., Borros Arneth, Christoph Hiemke, et al.. (2006). CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine. Journal of Clinical Pharmacy and Therapeutics. 31(5). 493–502. 178 indexed citations
18.
Gilles, Maria, Michael Deuschle, Mohamed E. E. Shams, et al.. (2005). Paroxetine Serum Concentrations in Depressed Patients and Response to Treatment. Pharmacopsychiatry. 38(3). 118–121. 23 indexed citations
19.
Shams, Mohamed E. E., Christoph Hiemke, & Sebastian Härtter. (2004). Therapeutic Drug Monitoring of the Antidepressant Mirtazapine and Its N-Demethylated Metabolite in Human Serum. Therapeutic Drug Monitoring. 26(1). 78–84. 23 indexed citations
20.
Grözinger, Michael, Aleksandra Dragičević, Christoph Hiemke, et al.. (2003). Melperone is an Inhibitor of the CYP2D6 Catalyzed O-demethylation of Venlafaxine. Pharmacopsychiatry. 36(1). 3–6. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hedi Schelleman Breakdown of academic impact, for papers by Menger Chung Breakdown of academic impact, for papers by Mahesh N. Samtani Breakdown of academic impact, for papers by Jesús Reviriego Breakdown of academic impact, for papers by Sang-Goo Shin Breakdown of academic impact, for papers by Mike Ufer Breakdown of academic impact, for papers by Kyoung Soo Lim Breakdown of academic impact, for papers by David W. J. Clark Breakdown of academic impact, for papers by Prajakti A. Kothare Breakdown of academic impact, for papers by J. Van Harten
Rankless by CCL
2026